Crossmark

Efficacy of Biejiajian Pill on Intestinal Microbiota in Patients with Hepatitis B Cirrhosis/Liver Fibrosis: A Randomized Double-Blind Controlled Trial

Crossref DOI link: https://doi.org/10.1007/s11655-023-3542-2

Published Online: 2023-05-24

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chi, Xin

Cheng, Dan-ying

Sun, Xiu

Liu, Shun-ai

Wang, Rong-bing

Chen, Qin

Xing, Hui-chun
License Information

Text and Data Mining valid from 2023-05-24

Version of Record valid from 2023-05-24
More Information

Article History

Accepted: 18 October 2022

First Online: 24 May 2023

Conflict of Interest

: Chen Q is a staff of China Traditional Chinese Medicine Holding Co., Ltd. The authors declare that China Traditional Chinese

Document is current

Any future updates will be listed below